Time-to-event voxel-based techniques to assess regional atrophy associated with MCI risk of progression to AD. - Prashanthi Vemuri; Stephen D. Weigand; David S. Knopman; Kejal Kantarci; Bradley F. Boeve; Ronald C. Petersen; Clifford R. Jack Jr. (NeuroImage, 2011)

Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's disease. - Prashanthi Vemuri; Matthew L. Senjem; Jeffrey L. Gunter; Emily S. Lundt; Nirubol Tosakulwong; Stephen D. Weigand; Bret J. Borowski; Matt A. Bernstein; Samantha M. Zuk; Val J. Lowe; David S. Knopman; Ronald C. Petersen; et al. (NeuroImage, 2015)

Optimizing PiB-PET SUVR change-over-time measurement by a large-scale analysis of longitudinal reliability, plausibility, separability, and correlation with MMSE. - Christopher G. Schwarz; Matthew L. Senjem; Jeffrey L. Gunter; Nirubol Tosakulwong; Stephen D. Weigand; Bradley J. Kemp; Anthony J. Spychalla; Prashanthi Vemuri; Ronald C. Petersen; Val J. Lowe; Clifford R. Jack Jr. (NeuroImage, 2017)

Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers. - Petrice M. Cogswell; Heather J. Wiste; Matthew L. Senjem; Jeffrey L. Gunter; Stephen D. Weigand; Christopher G. Schwarz; Arvin Arani; Terry M. Therneau; Val J. Lowe; David S. Knopman; Hugo Botha; Jonathan Graff-Radford; et al. (NeuroImage, 2021)

CSF dynamics as a predictor of cognitive progression. - Petrice M. Cogswell; Stephen D. Weigand; Heather J. Wiste; Jeffrey L. Gunter; Jonathan Graff-Radford; David T. Jones; Christopher G. Schwarz; Matthew L. Senjem; David S. Knopman; Ronald C. Petersen; Clifford R. Jack Jr. (NeuroImage, 2021)

Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation. - Christopher G. Schwarz; Terry M. Therneau; Stephen D. Weigand; Jeffrey L. Gunter; Val J. Lowe; Scott A. Przybelski; Matthew L. Senjem; Hugo Botha; Prashanthi Vemuri; Kejal Kantarci; Bradley F. Boeve; Jennifer L. Whitwell; et al. (NeuroImage, 2021)

Response to "On the reproducibility of quantitative susceptibility mapping and its potential as a clinical biomarker: A comment on Cogswell et al. 2021". - Petrice M. Cogswell; Heather J. Wiste; Stephen D. Weigand; Terry M. Therneau; Clifford R. Jack Jr. (NeuroImage, 2022)